» Articles » PMID: 27835610

Roles of Calpain-calpastatin System (CCS) in Human T Cell Activation

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Nov 12
PMID 27835610
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The immune response is determined by the speed of the T cell reaction to antigens assured by a state of readiness for proliferation and cytokine secretion. Proliferation, apoptosis and motion of many cell types are controlled by cytoplasmic proteases - µ- and m-calpain - and their inhibitor calpastatin, together forming the "calpain-calpastatin system" (CCS), assumed to modify their targets only upon activation-dependent cytoplasmic Ca2+ increase. Contrastingly to this notion, using quantitative real time PCR and semiquantitative flow cytometry respectively, we show here that the CCS genes are constitutively expressed, and that both calpains are constitutively active in resting, circulating human CD4+ and CD8+ lymphocytes. Furthermore, we demonstrate that calpain inhibition in the resting T cells prevents them from proliferation in vitro and greatly reduces secretion of multiple cytokines. The mechanistic reason for these effects of calpain inhibition on T cell functions might be the demonstrated significant reduction of the expression of active (phosphorylated) upstream signalling molecules, including the phospholipase C gamma, p56Lck and NFκB, in the inhibitor-treated cells. Thus, we propose that the constitutive, self-regulatory calpain-calpastatin system activity in resting human T cells is a necessary, controlling element of their readiness for complex and effective response to antigenic challenge.

Citing Articles

A Putative Role for TRPC6 in Immune-Mediated Kidney Injury.

t Hart D, van der Vlag J, Nijenhuis T Int J Mol Sci. 2023; 24(22).

PMID: 38003608 PMC: 10671681. DOI: 10.3390/ijms242216419.


Proteostasis in T cell aging.

Gressler A, Leng H, Zinecker H, Simon A Semin Immunol. 2023; 70:101838.

PMID: 37708826 PMC: 10804938. DOI: 10.1016/j.smim.2023.101838.


Longevity, Centenarians and Modified Cellular Proteodynamics.

Frankowska N, Bryl E, Fulop T, Witkowski J Int J Mol Sci. 2023; 24(3).

PMID: 36769212 PMC: 9918038. DOI: 10.3390/ijms24032888.


Proteolysis dysfunction in the process of aging and age-related diseases.

Frankowska N, Lisowska K, Witkowski J Front Aging. 2022; 3:927630.

PMID: 35958270 PMC: 9361021. DOI: 10.3389/fragi.2022.927630.


Immunosenescence and COVID-19.

Witkowski J, Fulop T, Bryl E Mech Ageing Dev. 2022; 204:111672.

PMID: 35378106 PMC: 8975602. DOI: 10.1016/j.mad.2022.111672.


References
1.
Schaecher K, Goust J, Banik N . The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites. Neurochem Res. 2004; 29(7):1443-51. DOI: 10.1023/b:nere.0000026410.56000.dd. View

2.
Witkowski J, Bryl E . Paradoxical age-related cell cycle quickening of human CD4(+) lymphocytes: a role for cyclin D1 and calpain. Exp Gerontol. 2004; 39(4):577-85. DOI: 10.1016/j.exger.2003.10.028. View

3.
Cressman C, Mohan P, Nixon R, Shea T . Proteolysis of protein kinase C: mM and microM calcium-requiring calpains have different abilities to generate, and degrade the free catalytic subunit, protein kinase M. FEBS Lett. 1995; 367(3):223-7. DOI: 10.1016/0014-5793(95)00543-i. View

4.
Adachi Y, Sugamura K, Lee W, Yodoi J, Maki M, Murachi T . Expression of calpain II gene in human hematopoietic system cells infected with human T-cell leukemia virus type I. J Biol Chem. 1992; 267(27):19373-8. View

5.
Feske S, Wulff H, Skolnik E . Ion channels in innate and adaptive immunity. Annu Rev Immunol. 2015; 33:291-353. PMC: 4822408. DOI: 10.1146/annurev-immunol-032414-112212. View